Finally, we explore whether the observed changes in gene expression levels of HSP90, HSP60 and GDNF in MS patients compared to the control group are connected to parallel alterations in the levels of the proteins expressed by these genes (Figure 3). This evidence concerns the gene HSPD1 and myeloid sarcoma.